세계의 고효능 원료의약품(HPAPI) 시장 : 합성(바이오 API, 합성 API), 용도, 지역(아메리카, 아시아태평양,＆유럽, 중동＆아프리카)별 예측(-2027년) - COVID-19의 누적 영향

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 고효능 원료의약품(HPAPI) 시장 규모는 2021년에 248억 2,000만 달러, 2022년에는 281억 달러에 달할 것으로 추정되고, 2027년에는 CAGR 13.49%로 성장해 530억 4,000만 달러에 달할 것으로 예측됩니다.

본 보고서는 다음 질문에 대한 답변이 될 것입니다.

• 고효능 원료의약품(HPAPI) 세계 시장의 규모 및 예측은?
• 예측기간 중 세계 고효능 원료의약품(HPAPI) 시장을 형성하는 COVID-19의 저해요인 및 영향은 무엇인가?
• 고효능 원료의약품(HPAPI) 세계 시장의 예측기간 중 투자해야 할 제품/부문/용도/분야는 무엇인가?
• 고효능 원료의약품(HPAPI) 세계 시장의 경쟁 전략 창은?
• 고효능 원료의약품(HPAPI) 세계 시장의 기술 동향과 규제 체계는?
• 고효능 원료의약품(HPAPI) 세계 시장 주요 벤더의 시장 점유율은?
• 고효능 원료의약품(HPAPI) 세계 시장 참여에 적합한 모드와 전략적 수단은 무엇인가?

목차

제1장 서문

• 조사 목적
• 시장 세분화와 범위
• 조사 대상 연도
• 통화와 가격
• 언어
• 제한
• 가정
• 이해관계자

제2장 조사 방법

• 정의 : 조사 목적
• 결정 : 조사 디자인
• 준비 : 조사표 작성
• 수집 : 데이터 소스
• 분석 : 데이터 해석
• 정식화 : 데이터 검증
• 출판 : 조사 보고서 작성
• 반복 : 보고서 업데이트

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

• 시장 역학
  • 성장 촉진요인
  • 성장 저해요인
  • 비즈니스 기회
  • 과제
  • COVID-19의 누적 영향

  제6장고효능 원료의약품(HPAPI) 시장 : 합성별

  • Biotech API
  • Synthetic AP

  제7장고효능 원료의약품(HPAPI) 시장 : 용도별

  • 녹내장
  • 호르몬 불균형
  • 종양학

  제8장 아메리카의 고효능 원료의약품(HPAPI) 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

  제9장 아시아태평양의 고효능 원료의약품(HPAPI) 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

  제10장 유럽, 중동 및 아프리카의 고효능 원료의약품(HPAPI) 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

  제11장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 주요 기업별 시장 점유율 분석
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 계약/협업/파트너십
    • 신제품 출시 및 개선
    • 투자 및 펀딩
    • 수상/표창/확대

  제12장 기업 개요

  • AbbVie Inc.
  • API Pharma Tech
  • Astrazeneca
  • Asymchem Inc.
  • Aurobindo Pharma
  • BASF SE
  • Bayer AG
  • BDR Pharmaceuticals Internationals Pvt. Ltd.
  • Bristol-Myers Squibb Company
  • C.H. Boehringer Sohn AG & Ko. KG
  • CARBOGEN AMCIS AG
  • Eli Lilly and Company
  • F Hoffmann La Roche Ltd
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

  제13장 부록

  • 논의 가이드
  • 라이선스와 가격에 대해
  LSH 22.08.03

LIST OF FIGURES

• FIGURE 1. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH PROCESS
• FIGURE 2. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2021 VS 2027 (USD BILLION)
• FIGURE 3. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 4. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
• FIGURE 5. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2027
• FIGURE 7. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
• FIGURE 8. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (%)
• FIGURE 9. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (USD BILLION)
• FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2027
• FIGURE 11. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, 2019-2027 (USD BILLION)
• FIGURE 12. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 13. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, 2019-2027 (USD BILLION)
• FIGURE 14. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 15. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
• FIGURE 16. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
• FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2027
• FIGURE 18. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, 2019-2027 (USD BILLION)
• FIGURE 19. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 20. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, 2019-2027 (USD BILLION)
• FIGURE 21. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 22. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
• FIGURE 23. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
• FIGURE 24. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 25. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
• FIGURE 26. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
• FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2027
• FIGURE 28. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 29. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 30. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 31. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 32. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 33. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
• FIGURE 34. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
• FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2027
• FIGURE 36. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 37. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
• FIGURE 38. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
• FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2027
• FIGURE 40. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 41. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 42. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 43. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 44. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 45. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 46. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 47. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 48. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 49. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 50. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 51. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 52. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
• FIGURE 53. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
• FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2027
• FIGURE 55. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 56. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 57. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 58. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 59. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 60. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 61. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 62. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 63. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 64. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 65. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• FIGURE 66. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX, 2021
• FIGURE 67. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2021
• FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE

LIST OF TABLES

• TABLE 1. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
• TABLE 3. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 4. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
• TABLE 5. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 6. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY REGION, 2019-2027 (USD BILLION)
• TABLE 7. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 8. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY STATE, 2019-2027 (USD BILLION)
• TABLE 9. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 10. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 11. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY REGION, 2019-2027 (USD BILLION)
• TABLE 12. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 13. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY STATE, 2019-2027 (USD BILLION)
• TABLE 14. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 15. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 16. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 17. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY REGION, 2019-2027 (USD BILLION)
• TABLE 18. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 19. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY STATE, 2019-2027 (USD BILLION)
• TABLE 20. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 21. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 22. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY REGION, 2019-2027 (USD BILLION)
• TABLE 23. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 24. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY STATE, 2019-2027 (USD BILLION)
• TABLE 25. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 26. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 27. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
• TABLE 28. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 29. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
• TABLE 30. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 31. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 32. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 33. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 34. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 35. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 36. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 37. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 38. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 39. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 40. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 41. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 42. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 43. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 44. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 45. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 46. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 47. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 48. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 49. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
• TABLE 50. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 51. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 52. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 53. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 54. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 55. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 56. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 57. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 58. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 59. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 60. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 61. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 62. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 63. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 64. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 65. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 66. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 67. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 68. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 69. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 70. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 71. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 72. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 73. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 74. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 75. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 76. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 77. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 78. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 79. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 80. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 81. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 82. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 83. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 84. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 85. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 86. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 87. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 88. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 93. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 94. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 95. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 96. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 97. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 98. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 99. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 100. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 101. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 102. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 103. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 104. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 105. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 106. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 107. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 108. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 109. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 110. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 111. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 112. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 113. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 114. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 115. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 116. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 117. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 118. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 119. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 120. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 121. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 122. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 123. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
• TABLE 124. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
• TABLE 125. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
• TABLE 126. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
• TABLE 127. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
• TABLE 128. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
• TABLE 129. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RANKING
• TABLE 130. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2021
• TABLE 131. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET MERGER & ACQUISITION
• TABLE 132. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
• TABLE 133. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
• TABLE 134. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET INVESTMENT & FUNDING
• TABLE 135. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET AWARD, RECOGNITION, & EXPANSION
• TABLE 136. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LICENSE & PRICING

The Global High Potency Active Pharmaceutical Ingredients Market size was estimated at USD 24.82 billion in 2021 and expected to reach USD 28.10 billion in 2022, and is projected to grow at a CAGR 13.49% to reach USD 53.04 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the High Potency Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Synthesis, the market was studied across Biotech API and Synthetic API.

Based on Application, the market was studied across Glaucoma, Hormonal Imbalance, and Oncology.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for High Potency Active Pharmaceutical Ingredients market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the High Potency Active Pharmaceutical Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global High Potency Active Pharmaceutical Ingredients Market, including AbbVie Inc., API Pharma Tech, Astrazeneca, Asymchem Inc., Aurobindo Pharma, BASF SE, Bayer AG, BDR Pharmaceuticals Internationals Pvt. Ltd., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Ko. KG, CARBOGEN AMCIS AG, Eli Lilly and Company, F Hoffmann La Roche Ltd, Lonza Group AG, Merck & Co., Inc., Novartis AG, Pfizer Inc, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report provides insights on the following pointers:

• 1. Market Penetration: Provides comprehensive information on the market offered by the key players
• 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
• 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
• 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
• 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

• 1. What is the market size and forecast of the Global High Potency Active Pharmaceutical Ingredients Market?
• 2. What are the inhibiting factors and impact of COVID-19 shaping the Global High Potency Active Pharmaceutical Ingredients Market during the forecast period?
• 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global High Potency Active Pharmaceutical Ingredients Market?
• 4. What is the competitive strategic window for opportunities in the Global High Potency Active Pharmaceutical Ingredients Market?
• 5. What are the technology trends and regulatory frameworks in the Global High Potency Active Pharmaceutical Ingredients Market?
• 6. What is the market share of the leading vendors in the Global High Potency Active Pharmaceutical Ingredients Market?
• 7. What modes and strategic moves are considered suitable for entering the Global High Potency Active Pharmaceutical Ingredients Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Ongoing expansion of pharmaceutical and CDMO industries across the globe
    • 5.1.1.2. Significant investments in drug discovery and development
    • 5.1.1.3. Rising requirement for targeted medicines by the oncology sector
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with development of safe environment for manufacturing HPAPI
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable governmental approvals for new molecular entities
    • 5.1.3.2. Ongoing research and development activities (R&D) for novel HPAPI
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with cytotoxic nature of high potency APIs
• 5.2. Cumulative Impact of COVID-19

6. High Potency Active Pharmaceutical Ingredients Market, by Synthesis

• 6.1. Introduction
• 6.2. Biotech API
• 6.3. Synthetic API

7. High Potency Active Pharmaceutical Ingredients Market, by Application

• 7.1. Introduction
• 7.2. Glaucoma
• 7.3. Hormonal Imbalance
• 7.4. Oncology

8. Americas High Potency Active Pharmaceutical Ingredients Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand

10. Europe, Middle East & Africa High Potency Active Pharmaceutical Ingredients Market

• 10.1. Introduction
• 10.2. France
• 10.3. Germany
• 10.4. Italy
• 10.5. Netherlands
• 10.6. Qatar
• 10.7. Russia
• 10.8. Saudi Arabia
• 10.9. South Africa
• 10.10. Spain
• 10.11. United Arab Emirates
• 10.12. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
  • 11.1.1. Quadrants
  • 11.1.2. Business Strategy
  • 11.1.3. Product Satisfaction
• 11.2. Market Ranking Analysis
• 11.3. Market Share Analysis, By Key Player
• 11.4. Competitive Scenario
  • 11.4.1. Merger & Acquisition
  • 11.4.2. Agreement, Collaboration, & Partnership
  • 11.4.3. New Product Launch & Enhancement
  • 11.4.4. Investment & Funding
  • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

• 12.1. AbbVie Inc.
• 12.2. API Pharma Tech
• 12.3. Astrazeneca
• 12.4. Asymchem Inc.
• 12.5. Aurobindo Pharma
• 12.6. BASF SE
• 12.7. Bayer AG
• 12.8. BDR Pharmaceuticals Internationals Pvt. Ltd.
• 12.9. Bristol-Myers Squibb Company
• 12.10. C.H. Boehringer Sohn AG & Ko. KG
• 12.11. CARBOGEN AMCIS AG
• 12.12. Eli Lilly and Company
• 12.13. F Hoffmann La Roche Ltd
• 12.14. Lonza Group AG
• 12.15. Merck & Co., Inc.
• 12.16. Novartis AG
• 12.17. Pfizer Inc
• 12.18. Sanofi S.A.
• 12.19. Teva Pharmaceutical Industries Ltd.
• 12.20. Viatris Inc.

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing